DiaMedica Therapeutics Inc.
DMAC
$6.05
$0.091.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.77M | -31.93M | -29.58M | -27.00M | -24.44M |
| Total Depreciation and Amortization | 43.00K | 43.00K | 35.00K | 42.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.99M | 2.30M | 1.73M | 1.27M | 817.00K |
| Change in Net Operating Assets | 675.00K | 1.85M | 2.16M | 3.12M | 1.51M |
| Cash from Operations | -29.06M | -27.73M | -25.65M | -22.57M | -22.08M |
| Capital Expenditure | -40.00K | -41.00K | -34.00K | -28.00K | -25.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.15M | -4.94M | 15.23M | 11.01M | 8.59M |
| Cash from Investing | -2.19M | -4.98M | 15.20M | 10.98M | 8.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -11.00K | -11.00K | -11.00K | -9.00K |
| Issuance of Common Stock | 44.29M | 32.37M | 506.00K | 12.10M | 12.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00K | -456.00K | -- | -- | -- |
| Cash from Financing | 43.88M | 31.91M | 495.00K | 12.09M | 11.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.62M | -808.00K | -9.96M | 492.00K | -1.52M |